Ekso Bionics Holdings, Inc. (EKSO)

Market Cap	8.33M
Revenue (ttm)	14.65M
Net Income (ttm)	-11.31M
Shares Out	2.61M
EPS (ttm)	-6.58
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,451
Open	3.040
Previous Close	3.040
Day's Range	3.036 - 3.240
52-Week Range	2.730 - 19.200
Beta	0.89
Analysts	Strong Buy
Price Target	34.75 (+989.34%)
Earnings Date	Jul 28, 2025

About EKSO

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot ort...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2005
• Employees: 66
• Stock Exchange: NASDAQ
• Ticker Symbol: EKSO
• Website: https://www.eksobionics.com

Financial Performance

In 2024, Ekso Bionics Holdings's revenue was $17.93 million, a decrease of -1.94% compared to the previous year's $18.28 million. Losses were -$11.33 million, -25.45% less than in 2023.

Analyst Forecast

According to 2 analysts, the average rating for EKSO stock is "Strong Buy." The 12-month stock price target is $34.75, which is an increase of 989.34% from the latest price.

Price Target

$34.75

(989.34% upside)

Analyst Consensus: Strong Buy